Cargando…

MOG antibodies in combined central and peripheral demyelination syndromes

Detalles Bibliográficos
Autores principales:	Vazquez Do Campo, Rocio, Stephens, Alana, Marin Collazo, I. Vanessa, Rubin, Devon I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147156/ https://www.ncbi.nlm.nih.gov/pubmed/30246057 http://dx.doi.org/10.1212/NXI.0000000000000503

Ejemplares similares

Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 Antibodies: Case Report
por: Pegat, Antoine, et al.
Publicado: (2022)

Neurofascin-155 as a putative antigen in combined central and peripheral demyelination
por: Cortese, Andrea, et al.
Publicado: (2016)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
por: Morris, Katrina A., et al.
Publicado: (2015)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Reversible paraspinal muscle hyperintensity in anti-MOG antibody–associated transverse myelitis
por: Pandit, Lekha, et al.
Publicado: (2017)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports
por: Körtvélyessy, Peter, et al.
Publicado: (2017)

Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies
por: Elterefi, Alanood E, et al.
Publicado: (2022)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody–Associated Disease
por: Syc-Mazurek, Stephanie B., et al.
Publicado: (2022)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Expanding the MOG phenotype: Brainstem encephalitis with punctate and curvilinear enhancement
por: Matesanz, Susan, et al.
Publicado: (2019)

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014)

Brain histopathological study and prognosis in MOG antibody‐associated demyelinating pseudotumor
por: Shu, Yaqing, et al.
Publicado: (2019)

COVID-19 vaccine associated demyelination & its association with MOG antibody
por: Netravathi, M., et al.
Publicado: (2022)

Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child
por: Carrera-García, Laura, et al.
Publicado: (2019)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
por: Berg, Carsten Tue, et al.
Publicado: (2017)

Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
por: Tzartos, John S., et al.
Publicado: (2020)

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019)

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Combined central and peripheral demyelination
por: Menon, Bindu, et al.
Publicado: (2014)

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
por: Hacohen, Yael, et al.
Publicado: (2019)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease in a 11 Year Old with COVID-19 Infection
por: Khan, Archana, et al.
Publicado: (2021)

Central and peripheral demyelination
por: Mehndiratta, Man Mohan, et al.
Publicado: (2014)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Autopsy-proven demyelination associated with infliximab treatment
por: Bradshaw, Michael J., et al.
Publicado: (2016)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Refractory MOG-Associated Demyelinating Disease in a Pediatric Patient
por: Kroenke, Eve, et al.
Publicado: (2022)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Myelodysplastic syndrome with progressive multifocal predominantly pontine demyelination
por: Bhattacharyya, Shamik, et al.
Publicado: (2015)

Asymptomatic CNS demyelination related to TNF-α inhibitor therapy
por: Ali, Farwa, et al.
Publicado: (2016)

CNS-disseminated Angiostrongylus cantonensis mimicking atypical demyelinating disease
por: Long, Daniel, et al.
Publicado: (2019)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Genetic Creutzfeldt-Jakob disease mimicking chronic inflammatory demyelinating polyneuropathy
por: Weckhuysen, Dorien, et al.
Publicado: (2015)

Measles–rubella vaccine–associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child
por: Otiv, Madhumati, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c668667ut4ld44eobku6qo5n1d